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This study focused on an extract from fermented flour from the Lady Joy variety of
the common bean Phaseolus vulgaris. The extract, Lady Joy lysate (Lys LJ), is enriched
in antioxidant compounds during the fermentation. We assessed it for its protective
effect on endothelial cells treated with oxidized-LDL (ox-LDL). The oxidative stress
was determined by measuring the contents of thiobarbituric acid-reactive substances
and reactive oxygen metabolites. ICAM-1, ET-1 and IL-6 concentrations were assessed
using ELISA. LOX-1 and CHOP expression were analyzed using both quantitative
RT-PCR and ELISA or western blotting. Ox-LDL treatment induced significant oxidative
stress, which was strongly reduced by pre-treatment with the extract. The ox-LDL
exposure significantly enhanced ICAM-1, IL-6 and ET-1 levels over basal levels.
Lys LJ pre-treatment exerted an inhibitory effect on ox-LDL-induced endothelial
activation with ICAM-1 levels comparable to those for the untreated cells. IL-6 and
ET-1 production, although reduced, was still significantly higher than for the control.
Both LOX-1 and CHOP expression were upregulated after ox-LDL exposure, but this
effect was significantly decreased after Lys LJ pre-treatment. Lys LJ alone did not alter
the ICAM-1, IL-6 and ET-1 concentrations or CHOP expression, but it did significantly
lower the LOX-1 protein level. Our data suggest that Lys LJ is an effective antioxidant
that is able to inhibit the oxidation process, but that it is only marginally active against
inflammation and ET-1 production in HMEC-1 exposed to ox-LDL.
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Atherosclerosis is one of the major causes of cardiovascular disease. Szmitko et al. [1]
describe it as a progressive and dynamic disease arising from inflammatory injury and
endothelial dysfunction. Together with inflammatory mediators, endothelial dysfunction
may contribute to different stages of atherosclerosis, including lesion formation and
progression, plaque rupture, hemorrhage and thrombosis, and it is an early hallmark of
the condition [2–4].
Vascular homeostasis is characterized by a tightly regulated action on vascular tone,
cellular adhesion, vascular smooth muscle migration and resistance to thrombosis. It
arises from a balance between vasodilators and vasoconstrictors, pro- and antioxidants,
and pro- and anti-inflammatory molecules [2, 5].
Endothelial dysfunction occurs due to decreased nitric oxide bioavailability and an
increased level of endothelin-1 (ET-1), angiotensin II and oxidants, which contribute to a
disequilibrium in endothelium-derived relaxing and contracting factors [4]. Endothelial
activation arises from an altered expression of cell surface adhesion molecules, such as
intracellular adhesion molecule (ICAM-1); vascular cell adhesion molecule (VCAM) and
E-selectin; pro-inflammatory cytokines such as tumor necrosis factor alpha (TNF-α) and
interleukin-6; and vasoactive mediators (prostaglandins, ET-1 and nitric oxide) [6]. ET-1
is one of the most potent vasoconstrictor peptides. It is synthesized and released mainly
by the endothelial cells, and is also involved in the proliferation and hypertrophy of
smooth muscle cells [7].
In the pathogenesis of atherosclerosis, oxidized low-density lipoproteins (ox-LDL)
cause injury, activation and dysfunction of the endothelium via lectin-like oxidized
low-density lipoprotein receptor-1 (LOX-1), which is overexpressed in both early and
advanced atherosclerotic lesions [1]. Under conditions of hypertension, hypercholestero-
lemia and diabetes, all of which are pathological states characterized by chronic oxidative
stress and high ox-LDL levels, LOX-1 is highly expressed in the blood vessels [1, 8].
Identified as the major receptor for ox-LDL uptake in the endothelial cells, LOX-1 has
also been found in macrophages, platelets, cardiac myocytes and vascular smooth muscle
cells [1, 9, 10]. Through LOX-1 upregulation, ox-LDL induces increased levels of intra-
cellular reactive oxygen species (ROS), which contribute to transcription-dependent
adhesion molecule synthesis and expression via the activation of nuclear factor-kB
(NF-kB) [1, 11].
NF-kB is an oxidant-sensitive transcription factor that plays a key role in the expression
of pro-inflammatory genes, including interleukin-6 (IL-6) [12], a multifunctional cytokine
that is widely implicated in cardiovascular disease. IL-6 secretion is upregulated in
response to inflammation, angiotensin II and oxidative stress [4, 12].
Over the last decade, endoplasmic reticulum (ER) stress, often referred to as the
unfolded protein response (UPR), has been recognized as a relevant factor in the
promotion of atherosclerosis. Ox-LDL has emerged as an inducer of ER stress signaling
in cultured endothelial cells through a mechanism involving altered ER calcium meta-
bolism [13]. Ox-LDL also induces endothelial cell apoptosis via the LOX-1-dependent
ER stress pathway and through the activation of ER stress sensors (IRE1 and PERK)
and related pathways, which contribute to upregulation of the expression of DNA
damage-inducible transcript 3 (CHOP), an ER stress-responsive transcription factor
with pro-apoptotic activity [14].
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on endothelial function [15]. Epidemiological evidence suggests the existence of a
relationship between improved endothelial function and the consumption of foods
containing polyphenols in both healthy people and patients with cardiovascular disease
[16, 17]. Noll et al. [18] also showed that daily intake of a red wine phenolic extract
mainly composed of catechin and epicatechin had beneficial effects on plasma homo-
cysteine levels and endothelial dysfunction biomarker expression in hyperhomocys-
teinemic mice. Furthermore, foodstuffs rich in procyanidin compounds, such as apple
polyphenols and grape seed extracts, are reported to have an inhibitory effect on LOX-1
expression and ox-LDL binding to LOX-1 [19].
Common beans (Phaseolus vulgaris L.) are suggested to be nutraceutical due to their high
content of bioactive compounds that improve endothelial function and exert anti-apoptotic,
anti-aging, anti-tumor and anti-proliferative properties [20]. Cholesterol-lowering action
and an inverse association between legume consumption and ischemic heart disease, coron-
ary disease, type 2 diabetes and obesity have also been described [21, 22].
The recent increase in interest in fermented legumes as nutraceuticals with protective
effects against cardiovascular diseases has led to an increase in their production and
consumption [23]. Indeed, fermentation is now widely used to preserve and improve
the texture, flavor and digestibility of several foods [24], including legumes, where it
enhances the bioactive compound content and the antioxidant activity, decreasing
non-nutritional factors [23].
As previously described by La Marca et al. [25], the fermentation of a flour derived
from a genetically selected variety of P. vulgaris named Lady Joy yielded larger amounts
of antioxidants, specifically polyphenols and flavonoids, compared to the unfermented
flour. In this study, we investigated the effect of this fermented product (Lady Joy
lysate) on the functional properties of human microvascular endothelial cells (HMEC-1)
exposed to ox-LDL.Material and methods
Plant material
The Lady Joy bean is a variety of Phaseolus vulgaris L. It is genetically devoid of the toxic
constituent phytohemagglutinin and contains phaseolamin (an alpha-amylase inhibitor).
Flour was produced by grinding the seeds, and the Lady Joy lysate (Lys LJ) was produced
by fermenting and drying the flour. Lys LJ was extracted with distilled water, sonicated
and centrifuged at 3500 rpm in a Jouan CR3i centrifuge for 10 min at 4 °C. The super-
natant was collected, filtered (0.2 μm, VWR International PBI) and kept at 4 °C in the dark
until use. The extraction was carried out in triplicate. The Lady Joy (LJ) flour and lysate
compositions were detailed by La Marca et al. [25].LDL isolation and TBAR production
LDL isolation and oxidation were performed as previously described [26]. The degree of
oxidation was determined using a colorimetric method (Cayman Chemical) by measuring
thiobarbituric acid-reactive substances (TBARs) expressed as nmol of malondialdehyde
(MDA) per mg of LDL protein according to the method described by Esterbauer and
Cheeseman [27].
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The HMEC-1 line was obtained from the Centre for Disease Control. HMEC-1 cells
retain morphological, phenotypic and functional characteristics of normal human
microvascular endothelial cells. All of the media and medium supplements for cell
culture were purchased from Sigma-Aldrich.
Cells were grown in 199 medium (M199) supplemented with 10 % fetal bovine serum
(FBS), 1 % L-glutamine, 100 units/ml penicillin, 100 μg/ml streptomycin, 10 ng/ml
epidermal growth factor (EGF) and 1 μg/ml hydrocortisone at 37 °C in a humidified
5 % CO2 incubator.
In order to evaluate the effect of Lys LJ extract on cell viability, HMEC-1 cells were
incubated for 24 h with increasing doses of Lys LJ extract, corresponding to 0, 0.07, 0.7
and 1.4 mg/ml. The highest concentration devoid of toxic effects (i.e., with a cell viabi-
lity of over 95 %) was used in further investigations.
Before each treatment, HMEC-1 were pre-incubated for 48 h with M199 without
phenol red, containing antibiotics and 1 % FBS. Then, after 1 h pre-treatment in the
presence or absence of 0.7 mg/ml of Lys LJ extract, HMEC-1 were stimulated for 24 h
with or without 200 μg of apolipoprotein B (apo B) per ml of ox-LDL.Cell viability
The trypan blue exclusion test and the MTT assay were performed to evaluate cell
viability. The trypan blue exclusion test was used to count the number of viable cells
presented in a cell suspension. Cells were trypsinized, harvested and then 10 μl cell
suspension was mixed with 10 μl 0.4 % trypan blue. Unstained (viable) and stained
(nonviable) cells were counted separately in the hemacytometer.
The MTT assay measures mitochondrial activity in living cells. Briefly, cells were
incubated with 100 μl MTT (Sigma; 1 mg/ml) for 2 h at 37 °C in 5 % CO2. Upon
incubation, the medium was removed and the cells solubilized in 100 μl of 10 %
DMSO/90 % isopropanol. The amount of the dye released from the cells was quantified
by measuring the optical density at 540 nm using an Eti-System multiplate reader
(Sorin Biomedica). The optical density directly correlates with the amount of metabo-
lically active cells.Reactive oxygen metabolite production
Reactive oxygen metabolites (ROMs) were detected using a d-ROMs Kit (Diacron Inter-
national) following the manufacturer’s protocol. The results were expressed as a percen-
tage relative to the control.Quantitative RT-PCR
Total RNA was isolated from HMEC-1 using PureZOL RNA isolation reagent (Bio-Rad)
and reverse-transcribed to cDNA using an iScript cDNA Synthesis Kit (Bio-Rad) follow-
ing the manufacturer’s protocol. Quantitative PCR was performed using the SsoFast
EvaGreen Supermix (Bio-Rad) in the StepOnePlus Real-Time PCR System (Applied
Biosystems). Gene primers were designed using Beacon Designer Software (Premier
Biosoft International) and were:
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AGGAGGTCA-3’
CHOP forward 5’-GAGAGTGTTCAAGAAGGAAGTGTA-3’, reverse 5’-CCCGAAG
GAGAAAGGCAAT-3’
β-actin forward 5’-GAGATGCGT-TGTTACAGGAAG-3’, reverse 5’-TGGACTTGG
GAGAGGACT-3’
β-actin was used as the housekeeping gene. Samples were assayed in triplicate and
the gene expression was calculated using the 2−ΔΔCT relative quantification method.Immunoblot analysis
Western blot analysis was performed according to La Marca et al. [25]. The antibodies
used were anti-CHOP (1:500) and goat anti-rabbit (1:5000; Santa Cruz Biotechnology,
Inc.). Immunoreactive proteins were visualized with a chemiluminescence reaction kit
(EuroClone), and bands deriving from three independent experiments were electronically
scanned and quantified with ImageJ software.ELISA
The ICAM-1, ET-1 and IL-6 concentrations in the medium were measured using an
ELISA kit from Cayman Chemical. The LOX-1 protein level was evaluated via ELISA
with a kit from Aviscera Bioscience.Statistical analyses
Statistical analyses were performed using GraphPad Prism version 4.00 for Windows
(GraphPad Software). Assays were carried out in triplicate and the results were expressed
as the mean values ± SD. Differences between samples were analyzed via one-way analysis
of variance (ANOVA) with Dunnett’s multiple comparison test. A p value lower than 0.05
is considered significantly different.Results
As described by La Marca et al. [25], Lys LJ contained a significantly higher level of
polyphenols (3.8 ± 0.24 vs. 2.348 ± 0.05 mg GAE/g DW, p < 0.001) and flavonoids (2.1 ±
0.1 vs. 1.6 ± 0.1 mg CE/g DW, p < 0.01) compared to the equivalent unfermented flour. It
also showed a better antioxidant activity, as evaluated using the ORAC assay (1233 ± 23
vs. 730 ± 30 μmol TE/100 g DW, p < 0.001). However, the flavonol concentration was
reduced after fermentation (0.4 ± 0.1 and 1.6 ± 0.05 mg QE/g dw respectively, p < 0.0001)
and anthocyanins were not detected. Therefore, we tested the effect of the fermented bean
flour on human microvascular endothelial cells (HMEC-1) under oxidative conditions.
To identify the optimal treatment conditions and detect possible cytotoxic effects, we
used a toxicity curve with 0–1.4 mg/ml as the range of concentrations of Lys LJ extract.
The highest concentration that did not cause toxic effects (i.e., cell viability of over
95 % as determined using the Trypan Blue dye exclusion test and MTT assay) following
24 h exposure was used in further investigations (data not shown). As previously
described by Lubrano et al. [28], we used 200 μg of apo B/ml of ox-LDL to induce
oxidative stress. We investigated the effect of 24 h exposure to 200 μg/ml ox-LDL,
following 1 h pre-treatment with 0.7 mg/ml Lys LJ extract on HMEC-1 cells.
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TBARs, which are lipid peroxidation markers. Their level was significantly higher in
ox-LDL-exposed cells (10.9 nmole MDA/mg protein) than in untreated cells (1.76 nmole/
MDA/mg protein, ***p < 0.001 vs. the control; Fig. 1a). Moreover, Lys LJ pre-treatment
significantly reduced TBAR formation arising from ox-LDL exposure (&&&p < 0.001)
with values overlapping the control values (Fig. 1a). Otherwise, Lys LJ alone significantly
decreased TBAR concentration compared to the values under basal conditions (***p <
0.001; Fig. 1a).
Additionally, as shown in Fig. 1b, we detected a medium level of reactive oxygen
metabolites (ROMs), which are free radical-derived compounds. Their levels were
significantly increased by ox-LDL exposure (***p < 0.001 vs. the control). Although the
level was reduced by Lys LJ pre-treatment (&&p < 0.01 vs. ox-LDL) it was still signifi-
cantly higher than the control (**p < 0.01).
To identify the nutraceutical properties of Lys LJ, we tested its possible inhibitory
effect on LOX-1 and CHOP expression and on the level of ICAM-1, IL-6 and ET-1 in
the medium of endothelial cells following ox-LDL exposure. Quantitative PCR showed
the expected significant upregulation of both LOX-1 (***p < 0.001 vs. the control) and
CHOP (**p < 0.001 vs. the control) gene expression following ox-LDL treatment. This
was strongly inhibited by Lys LJ pre-treatment (&&&p < 0.001 and &&p < 0.01 vs.
ox-LDL, respectively). Conversely, Lys LJ treatment alone had no effect (Figs. 2a and 3a).
These results were also confirmed at the protein level as shown in Figs. 2b and 3b.
However, unlike with the gene expression, LOX-1 and CHOP proteins were reduced after
Lys LJ pretreatment (&&&p < 0.001 vs. ox-LDL) but were still higher than in the control
cells (***p < 0.001).
As shown in Fig. 4a–c, exposure of HMEC-1 to 200 μg/ml ox-LDL resulted in a
significant upregulation of ICAM-1 (**p < 0.01), IL-6 (**p < 0.01) and ET-1 (***p < 0.001)
concentrations in the medium compared to the untreated cells. Lys LJ pre-treatment
exerted an inhibitory effect on ox-LDL endothelial activation with ICAM-1 levels
overlapping the control values (Fig. 4a). Although Lys LJ pre-treatment of HMEC-1
cells exposed to ox-LDL reduced the levels of both IL-6 and ET-1, these levelsFig. 1 Quantification of the levels of TBARs (a) and reactive oxygen metabolites (b) in HMEC-1 cells pre-treated
for 1 h with or without 0.7 mg/ml Lys LJ extract, then exposed for 24 h to 200 μg of apolipoprotein B
(apo B) per ml of ox-LDL. Untreated cells were used as the control (CNT). Results are derived from triplicate
determinations and expressed as means ± SD. ANOVA with Dunnett’s multiple comparison test. *Significantly
different from the control: **p < 0.01; ***p < 0.001. &Significantly different from ox-LDL: &&p < 0.01; &&&p < 0.001
Fig. 2 Quantitative RT-PCR (a) and ELISA (b) determination of LOX-1 expression in HMEC-1 cells pre-treated
for 1 h with 0.7 mg/ml Lys LJ extract, then exposed for 24 h to 200 μg of apolipoprotein B (apo B) per ml of
ox-LDL. Untreated cells were used as the control (CNT). Results are derived from triplicate determinations and
expressed as means ± SD. ANOVA with Dunnett’s multiple comparison test. *Significantly different from the
control: ***p < 0.001. &Significantly different from ox-LDL: &&&p < 0.001
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to Lys LJ treatment alone produced no significant change in IL-6 or ET-1 levels.
Discussion
Solid-state fermentation has recently been extensively used to improve the nutritional
properties and enhance the bioactive compound content of certain foodstuffs, such as
black beans [29]. As previously described by La Marca et al. [25], the fermentation process
applied to Lady Joy bean flour increases the amount of antioxidants, in particular polyphe-
nols and flavonoids, and significantly increases the antioxidant capacity of the bean lysate
preparation compared to the unfermented flour. The same fermentation process applied
to an organic grain flour named Lisosan G showed similar results with beneficial effects
on HMEC-1 following ox-LDL exposure [30].
We previously showed improved human endothelial progenitor cell functions after Lys
LJ pre-treatment in terms of cell viability, adhesion capacity and senescence rate bothFig. 3 Quantitative RT-PCR (a) and western blot (b) analysis of CHOP expression in HMEC-1 pre-treated for 1 h
with 0.7 mg/ml Lys LJ extract, then exposed for 24 h to 200 μg of apolipoprotein B (apo B) per ml of ox-LDL.
Untreated cells were used as the control (CNT). The results are derived from triplicate determinations and
expressed as means ± SD. ANOVA with Dunnett’s multiple comparison test. *Significantly different from the
control: **p < 0.01; ***p < 0.001. &Significantly different from ox-LDL: &&p < 0.01; &&&p < 0.001
Fig. 4 ELISA determination of ICAM-1 (a), IL-6 (b) and ET-1 (c) production in the medium of HMEC-1 cells
pre-treated for 1 h with 0.7 mg/ml Lys LJ extract, then exposed for 24 h to 200 μg of apolipoprotein B
(apo B) per ml of ox-LDL. Untreated cells were used as the control (CNT). Results are derived from triplicate
determinations and expressed as means ± SD. ANOVA with Dunnett’s multiple comparison test. *Significantly
different from the control: *p < 0.05; **p < 0.01; ***p < 0.001. &Significantly different from ox-LDL: &p < 0.05;
&&p < 0.01; &&&p < 0.001
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the effect of Lys LJ on human erythrocytes exposed to a radical generator, showing
a good cellular antioxidant activity and a higher hemolysis inhibition following Lys
LJ pre-treatment. We also described good anti-mutagenic and antioxidant activity
following oxidative injury in the Saccharomyces cerevisiae D7 strain pre-treated
with Lys LJ extract [32].
To better define the nutraceutical properties of Lys LJ, we investigated the effect of
pre-treatment with the extract in human microvascular endothelial cells. Overall, our
findings show that Lys LJ pre-treatment could improve endothelial function otherwise
impaired by ox-LDL exposure. In particular, Lys LJ pre-treatment could counteract the
oxidation process arising from ox-LDL treatment and reduce the endothelial endo-
genous stress.
Thus, Lys LJ pre-treatment reduced the expression of LOX-1 at both the mRNA and
protein levels. They were otherwise upregulated by exposure to lipoperoxides or free
radical agents, which influences endothelial disfunction by promoting the generation of
superoxide anions, the inhibition of nitric oxide production and the enhanced adhesion
of monocytes to the endothelium [33, 34]. LOX-1 also contributes to inflammation and
smooth muscle cell proliferation, leading to atheroma formation at multiple levels
[35, 36]. The beneficial effects of Lys LJ were observed in these microvascular endothelial
cells as the reduction of CHOP expression at both the mRNA and protein levels, in
keeping with the earlier observations of La Marca et al. [25] with primary rat hepatocyte
cultures exposed to H2O2.
The inhibitory effects of Lys LJ pre-treatment on the induction of ICAM-1 by ox-LDL
treatment is noteworthy, where this pre-treatment completely inhibits the induction of
ICAM-1 into the medium of HMEC-1 cells following ox-LDL treatment. These results
are in keeping with a recent study in which flavonoids exhibited a good anti-inflammatory
effect and reduced ICAM-1 expression in human aortic endothelial cells [37]. A similar
effect was detected for HMEC-1 exposed to ox-LDL following pre-treatment with Lisosan
G [38], which contains a significant amount of polyphenols [31]. Lys LJ pre-treatment was
less effective with IL-6 and ET-1, where the increase in medium levels following ox-LDL
treatmen was only partially reduced.
A recent study showed a synergic action of olive oil and wine polyphenols in the
modulation of ox-LDL effects on oxidative stress [39]. Moreover, it has been demon-
strated that the polyphenol fraction of extra virgin olive oil protected endothelial cells
from free fatty acid-induced dysfunction by reversing ET-1 impairment [40]. Another
recent paper showed that, among polyphenols, only resveratrol and quercetin were
effective in decreasing H2O2-induced ET-1 overexpression in a dose-dependent manner
in human umbilical vein endothelial cells (HUVEC). Although those authors did not
provide a clear explanation for this, they suggested that these effects could depend
upon the chemical structure and/or the antioxidant activity. Others reported that these
two polyphenols showed the highest antioxidant capacities as measured by the ferric
reducing antioxidant power assay [41].
We can therefore assume that this fermented bean flour may reduce oxidative stress
by decreasing both lipoperoxides and free radicals. Our data also show an important
role of Lys LJ in reducing endothelial adhesiveness, one of the main events in endo-
thelial activation and plaque formation [42]. Indeed, adhesion of monocytes to the
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compete to recruit and promote cell–cell interaction between monocytes and endo-
thelial cells [43].
Conclusions
This study demonstrated the beneficial effects of a fermented bean flour lysate on human
microvascular endothelial cells exposed to oxidative injury. Our results suggest that Lys
LJ (Lady Joy lysate) is a strong antioxidant able to reduce the degree of oxidation, ER
stress and endothelial adhesiveness induced by ox-LDL treatment. However, it is poorly
active against inflammation and ET-1 induction resulting from pro-oxidant injury in
human microvascular endothelial cells. The fermentation process applied to the bean
flour is a useful procedure to enrich and ameliorate the nutritional properties of this
legume, which might prove to be a useful nutraceutical for preventing cardiovascular
diseases.
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